DK1791872T3 - Biotinylerede hexadecasaccharider, farmaceutiske præparater og anvendelse heraf - Google Patents

Biotinylerede hexadecasaccharider, farmaceutiske præparater og anvendelse heraf

Info

Publication number
DK1791872T3
DK1791872T3 DK05805571T DK05805571T DK1791872T3 DK 1791872 T3 DK1791872 T3 DK 1791872T3 DK 05805571 T DK05805571 T DK 05805571T DK 05805571 T DK05805571 T DK 05805571T DK 1791872 T3 DK1791872 T3 DK 1791872T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparations
biotinylated hexadecasaccharides
hexadecasaccharides
biotinylated
preparations
Prior art date
Application number
DK05805571T
Other languages
English (en)
Inventor
Philippe Duchaussoy
Jean Pascal Herault
Jean Marc Herbert
Maurice Petitou
Pierre Savi
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34948342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1791872(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK1791872T3 publication Critical patent/DK1791872T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials Engineering (AREA)
  • Vascular Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Surgery (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)
  • Saccharide Compounds (AREA)
DK05805571T 2004-09-09 2005-09-07 Biotinylerede hexadecasaccharider, farmaceutiske præparater og anvendelse heraf DK1791872T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0409557A FR2874924B1 (fr) 2004-09-09 2004-09-09 Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
PCT/FR2005/002218 WO2006030104A1 (fr) 2004-09-09 2005-09-07 Hexadecasaccharides biotinyles, leur preparation et leur utilisation

Publications (1)

Publication Number Publication Date
DK1791872T3 true DK1791872T3 (da) 2009-05-04

Family

ID=34948342

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05805571T DK1791872T3 (da) 2004-09-09 2005-09-07 Biotinylerede hexadecasaccharider, farmaceutiske præparater og anvendelse heraf

Country Status (39)

Country Link
US (3) US20070270342A1 (da)
EP (1) EP1791872B1 (da)
JP (1) JP5108519B2 (da)
KR (1) KR101223364B1 (da)
CN (1) CN101039963B (da)
AR (1) AR051286A1 (da)
AT (1) ATE420118T1 (da)
AU (1) AU2005284080B2 (da)
BR (1) BRPI0515078A (da)
CA (1) CA2577258C (da)
CY (1) CY1109126T1 (da)
DE (1) DE602005012287D1 (da)
DK (1) DK1791872T3 (da)
EA (1) EA012587B1 (da)
EC (1) ECSP077272A (da)
ES (1) ES2320576T3 (da)
FR (1) FR2874924B1 (da)
GT (1) GT200500250A (da)
HK (1) HK1113686A1 (da)
HN (1) HN2005000518A (da)
HR (1) HRP20090180T1 (da)
IL (1) IL181569A (da)
MA (1) MA28859B1 (da)
MX (1) MX2007002875A (da)
MY (1) MY140666A (da)
NI (1) NI200700063A (da)
NO (1) NO20071754L (da)
PA (1) PA8644201A1 (da)
PE (1) PE20060663A1 (da)
PL (1) PL1791872T3 (da)
PT (1) PT1791872E (da)
RS (1) RS50762B (da)
SI (1) SI1791872T1 (da)
SV (1) SV2006002221A (da)
TN (1) TNSN07053A1 (da)
TW (1) TW200612970A (da)
UY (1) UY29102A1 (da)
WO (1) WO2006030104A1 (da)
ZA (1) ZA200702255B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912409B1 (fr) * 2007-02-14 2012-08-24 Sanofi Aventis Heparines de bas poids moleculaire comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine leur procede de preparation,leur utilisation
FR2912408A1 (fr) * 2007-02-14 2008-08-15 Sanofi Aventis Sa Heparine comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine,leur procede de preparation,leur utilisation
TW201006479A (en) * 2008-07-18 2010-02-16 Sanofi Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2145624A1 (en) * 2008-07-18 2010-01-20 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
EP2233143A1 (en) * 2009-03-24 2010-09-29 Sanofi-Aventis Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment
FR2935387B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Hexadecasaccharides a activite antithrombotique comprenant une liaison covalente avec une chaine amine
FR2952935B1 (fr) 2009-11-20 2011-12-02 Sanofi Aventis Procede de preparation du n-biotinyl-6-aminocaproate de n succinimidyle

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563351C (en) 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
EP0300099A1 (en) 1987-07-20 1989-01-25 Akzo N.V. New pentasaccharides
IL102758A (en) 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (fr) 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
NZ264340A (en) 1993-09-01 1995-04-27 Akzo Nobel Nv Bisconjugate comprising two saccharides and a spacer, use in pharmaceutical compositions
FR2751334B1 (fr) 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773804B1 (fr) 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
FR2773801B1 (fr) 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine

Also Published As

Publication number Publication date
EA012587B1 (ru) 2009-10-30
SV2006002221A (es) 2006-01-13
WO2006030104A1 (fr) 2006-03-23
MX2007002875A (es) 2007-05-16
IL181569A (en) 2011-08-31
US8557968B2 (en) 2013-10-15
NI200700063A (es) 2008-03-07
DE602005012287D1 (de) 2009-02-26
FR2874924A1 (fr) 2006-03-10
ECSP077272A (es) 2007-03-29
CN101039963B (zh) 2011-07-27
EP1791872A1 (fr) 2007-06-06
GT200500250A (es) 2006-04-10
UY29102A1 (es) 2006-04-28
EA200700594A1 (ru) 2007-08-31
CN101039963A (zh) 2007-09-19
TNSN07053A1 (fr) 2008-06-02
ES2320576T3 (es) 2009-05-25
US20130004551A1 (en) 2013-01-03
KR101223364B1 (ko) 2013-01-16
US20100279960A1 (en) 2010-11-04
EP1791872B1 (fr) 2009-01-07
AU2005284080A1 (en) 2006-03-23
PT1791872E (pt) 2009-03-27
FR2874924B1 (fr) 2006-12-01
AR051286A1 (es) 2007-01-03
JP5108519B2 (ja) 2012-12-26
JP2008512538A (ja) 2008-04-24
MA28859B1 (fr) 2007-09-03
IL181569A0 (en) 2007-07-04
BRPI0515078A (pt) 2008-07-01
HRP20090180T1 (en) 2009-05-31
NO20071754L (no) 2007-04-02
CA2577258C (fr) 2013-05-21
CA2577258A1 (fr) 2006-03-23
HK1113686A1 (en) 2008-10-10
RS50762B (sr) 2010-08-31
ZA200702255B (en) 2008-09-25
PE20060663A1 (es) 2006-08-21
US20070270342A1 (en) 2007-11-22
SI1791872T1 (sl) 2009-06-30
PL1791872T3 (pl) 2009-06-30
US8703738B2 (en) 2014-04-22
PA8644201A1 (es) 2006-05-16
CY1109126T1 (el) 2014-07-02
AU2005284080B2 (en) 2011-10-13
ATE420118T1 (de) 2009-01-15
KR20070051887A (ko) 2007-05-18
TW200612970A (en) 2006-05-01
HN2005000518A (es) 2009-06-01
MY140666A (en) 2010-01-15

Similar Documents

Publication Publication Date Title
MA28489B1 (fr) Preparations pharmaceutiques
NO20052855D0 (no) Fosfonoksykinazolinderivater og farmasoytisk anvendelse derav.
NO20055246D0 (no) Heteroaromatisk pentasyklisk forbindelse og medisinsk anvendelse derav
DK1575618T3 (da) Dispergerbare farmaceutiske kombinationer
NO20053817D0 (no) Preparater og fremgangsmater for antiviral kombinasjonsterapi.
DK1708994T3 (da) Aryloxyalkylcarbamatderivater, fremstilling og anvendelse herfra inden for terapi
IL184288A0 (en) 18-methyl-19-nor-17-pregn-4-en-21,17-carbolactones and pharmaceutical preparations comprising the same
NO20051983D0 (no) 3-fenyl-substituert pyridoindolon, fremstilling derav og terapeutisk anvendelse derav.
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
DK1773796T3 (da) Oxopiperidinderivater, fremstilling deraf samt terapeutisk anvendelse deraf
DK1753725T3 (da) Tetra-hydro-iso-quinolinsulfonamidderivater, fremstilling og terapeutisk anvendelse heraf.
NO20053809D0 (no) Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav
DK1773829T3 (da) Aminotropanderivater, fremstilling og terapeutiske anvendelser heraf
DK1912644T3 (da) N-(arylalkyl)-1h-pyrrolopyridin-2-carboxamid-derivater, fremstilling deraf og terapeutisk anvendelse deraf
DK1590321T3 (da) Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
DK1513836T3 (da) Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf
DK1791872T3 (da) Biotinylerede hexadecasaccharider, farmaceutiske præparater og anvendelse heraf
DK1828137T3 (da) 4-Cycloalkyl-substituerede tetrahydroquinolinderivater og deres anvendelse som medikamenter
DE602005019913D1 (de) Therapeutische pyrazoloä3,4-büpyridine und -indazole
DK1940840T3 (da) 6-heteroarylpyridoindolon-derivater, fremstilling deraf og terapeutisk anvendelse deraf
NO20053805D0 (no) Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav
NO20042890L (no) Farmasoytiske preparater og fremgangsmate for fremstilling derav
DK1742947T3 (da) 6-substituerede pyridoindolanderivater, fremstilling og terapeutisk anvendelse heraf
IS8548A (is) Úðaþurrkaðar lyfjablöndur
NO20055142D0 (no) Diarylmetylidenpiperidinderivater, fremstillinger og anvendelser derav